Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). (Record no. 22039055)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02261 a2200601 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250516105706.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201302s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1549-490X |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1634/theoncologist.2011-0467 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Pautier, Patricia |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20130211 |
245 00 - TITLE STATEMENT | |
Title | Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study). |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The oncologist |
Date of publication, distribution, etc. | 2012 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1213-20 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Deoxycytidine |
General subdivision | analogs & derivatives |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Disease-Free Survival |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Docetaxel |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Dose-Response Relationship, Drug |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | France |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Granulocyte Colony-Stimulating Factor |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Leiomyosarcoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lenograstim |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Metastasis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasm Recurrence, Local |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Recombinant Proteins |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Taxoids |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Uterine Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gemcitabine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Floquet, Anne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Penel, Nicolas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Piperno-Neumann, Sophie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Isambert, Nicolas |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rey, Annie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Bompas, Emmanuelle |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cioffi, Angela |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Delcambre, Corinne |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cupissol, Didier |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Collin, Françoise |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Blay, Jean-Yves |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Jimenez, Marta |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Duffaud, Florence |
773 0# - HOST ITEM ENTRY | |
Title | The oncologist |
Related parts | vol. 17 |
-- | no. 9 |
-- | p. 1213-20 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1634/theoncologist.2011-0467">https://doi.org/10.1634/theoncologist.2011-0467</a> |
Public note | Available from publisher's website |
No items available.